story of the week
Avelumab Is Clinically Active and Safe in Advanced/Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Avelumab, an Anti-PD-L1 Antibody, in Patients With Locally Advanced or Metastatic Breast Cancer: A Phase 1b JAVELIN Solid Tumor Study
Breast Cancer Res Treat 2017 Oct 23;[EPub Ahead of Print], LY Dirix, I Takacs, G Jerusalem, P Nikolinakos, HT Arkenau, A Forero-Torres, R Boccia, ME Lippman, R Somer, M Smakal, LA Emens, B Hrinczenko, W Edenfield, J Gurtler, A von Heydebreck, HJ Grote, K Chin, EP HamiltonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.